Chronic Obstructive Pulmonary Disease News and Research RSS Feed - Chronic Obstructive Pulmonary Disease News and Research

The World Health Organisation (WHO) has described Chronic Obstructive Pulmonary Disorder (COPD) as a global epidemic; an estimated 210 million people have COPD worldwide and more than 3 million people died of the condition in 2005, which is equal to 5% of all deaths globally that year. Total deaths from COPD are projected to increase by more than 30% in the next 10 years without interventions to cut risks, particularly exposure to tobacco smoke.
Researchers discover olfactory receptors in human muscle cells of bronchi

Researchers discover olfactory receptors in human muscle cells of bronchi

Researchers identified two types of olfactory receptors in human muscle cells of bronchi. If those receptors are activated by binding an odorant, bronchi dilate and contract - a potential approach for asthma therapy. [More]
New drug could help decrease symptoms of asthma

New drug could help decrease symptoms of asthma

The first new asthma pill for nearly 20 years has the power to significantly reduce the severity of the condition, a study led by the University of Leicester has found. [More]
High medical costs force many Australians to skip healthcare treatment

High medical costs force many Australians to skip healthcare treatment

New research shows one in four chronically ill Australians is skipping healthcare because of high costs. [More]
Review highlights role of N-acetylcysteine in clinical management of COPD

Review highlights role of N-acetylcysteine in clinical management of COPD

Chronic Obstructive Pulmonary Disease (COPD) is one of the leading causes of death of United States and is associated with a significant number of hospital admissions per year among patients. [More]
Northwell Health receives grant to assess pulmonary rehabilitation via telehealth for Hispanic COPD patients

Northwell Health receives grant to assess pulmonary rehabilitation via telehealth for Hispanic COPD patients

Northwell Health's Feinstein Institute for Medical Research has been awarded a $1.5 million grant from the Patient-Centered Outcomes Research Institute to study whether home-based pulmonary rehabilitation improves quality of life and decreases hospitalization in Hispanic patients with moderate to severe chronic obstructive pulmonary disease (COPD). [More]
GSK, VentureWise partner to deliver independent educational program on COPD to GPs

GSK, VentureWise partner to deliver independent educational program on COPD to GPs

A new agreement between GlaxoSmithKline and VentureWise—part of the MedicineWise Group—will see an independent educational program delivered to GPs on the topic of chronic obstructive pulmonary disease. [More]
Scientists develop prediction score to identify older adults at risk of developing pneumonia

Scientists develop prediction score to identify older adults at risk of developing pneumonia

In a study published in the Journal of American Geriatrics Society, researchers developed a "prediction score" to help healthcare professionals determine which older adults might be most at risk for developing pneumonia. [More]

Pulmatrix announces positive results from Phase 1 study of novel dry powder formulation in COPD patients

Pulmatrix, Inc., today announced positive topline data from a Phase 1 pilot pharmacokinetic bioavailability trial of PUR0200. PUR0200 is a novel dry powder formulation of a currently marketed once daily bronchodilator, formulated in the company's proprietary iSPERSETM dry powder delivery technology. [More]
New opioid use among older adults with COPD linked to increased risk for respiratory-related death

New opioid use among older adults with COPD linked to increased risk for respiratory-related death

Older adults with chronic obstructive pulmonary disease who start using opioids have a more than two-fold higher risk of dying from a respiratory-related complication compared to non-opioid users, St. Michael's Hospital researchers have found. [More]
Deuteration offers alternative chorea treatment for Huntington disease patients

Deuteration offers alternative chorea treatment for Huntington disease patients

Treatment with a deuterated form of tetrabenazine has resulted in improved motor signs among patients with Huntington disease, making it a potential treatment for chorea, trial findings show. [More]
Simple 7-item screening device can help detect patients at risk for COPD

Simple 7-item screening device can help detect patients at risk for COPD

A simple 7-item screening tool can help clinicians identify patients at risk for chronic obstructive pulmonary disease (COPD), even if they are not experiencing any symptoms. [More]
Study highlights need to improve end-of-life care for all patients with serious illnesses

Study highlights need to improve end-of-life care for all patients with serious illnesses

Historically, efforts to improve end-of-life care have focused primarily on patients with cancer. But few studies have looked at the quality of end-of-life care for patients with other serious illnesses, such as lung, kidney or heart failure or dementia. [More]
Depression reduces COPD maintenance medication adherence in older adults

Depression reduces COPD maintenance medication adherence in older adults

A recent study in the Annals of the American Thoracic Society found that in a nationally representative sample of Medicare beneficiaries who were newly diagnosed with COPD, adherence to maintenance medications decreased with new episodes of depression. [More]
Researchers reveal novel mechanism of smoke induced collapse of protein homeostasis in COPD

Researchers reveal novel mechanism of smoke induced collapse of protein homeostasis in COPD

Few threats to public health are as perilous as cigarette smoking, with more than 435,000 Americans dying each year of tobacco-related pulmonary illnesses such as chronic obstructive pulmonary disease (COPD). [More]
E-cigarette use modifies gene expression important for upper airway immune defense

E-cigarette use modifies gene expression important for upper airway immune defense

When we smoke cigarettes, dozens of genes important for immune defense are altered in the epithelial cells that line the respiratory tract. Several of these changes likely increase the risk of bacterial infections, viruses, and inflammation. [More]
Rehabilitation programmes can help reverse frailty in older COPD patients

Rehabilitation programmes can help reverse frailty in older COPD patients

One in four patients with COPD referred for exercise rehabilitation are frail, but nevertheless can respond favourably to rehabilitation and their frailty can be reversed, finds a new study led by King's College London and Royal Brompton & Harefield NHS Foundation Trust. [More]
New study finds underutilization of PR therapy among older COPD patients

New study finds underutilization of PR therapy among older COPD patients

A new study from The University of Texas Medical Branch at Galveston investigating trends on the use of pulmonary rehabilitation therapy among older adults with chronic obstructive pulmonary disease found that this therapy was underutilized, despite its health benefits and cost effectiveness. [More]
New RNA aptamer can prevent pathogenic protein misfolding

New RNA aptamer can prevent pathogenic protein misfolding

Several diseases occur when mutations cause misfolding of proteins. These include "serpinopathies" which is a group of rare heritable diseases. They are caused by mutations of so-called "serpin" inhibitors of proteolytic enzymes involved in blood coagulation, tissue remodeling, and other important physiological functions. [More]
Correcting defective p73 gene function may be promising therapeutic strategy for chronic lung diseases

Correcting defective p73 gene function may be promising therapeutic strategy for chronic lung diseases

Rising global air pollution and increasing smoking prevalence in many developing nations will likely lead to a growing incidence of lung diseases such as chronic obstructive pulmonary disease (COPD), which currently affects more than 330 million people worldwide, is the third-leading cause of death and carries an estimated healthcare cost of $2.1 trillion. [More]
Readmission rates after major cancer procedures depend on patient cohort, hospital characteristics

Readmission rates after major cancer procedures depend on patient cohort, hospital characteristics

Readmission rates after complex cancer operations tend to be higher in hospitals that are considered to be vulnerable because they serve as safety nets in their communities or have a high number of Medicaid patients. [More]
Advertisement
Advertisement